The content on this site is intended for healthcare professionals only
Prof Christopher Marshall speaks to ecancer at the 2019 Cancer Research At Bath conference about PET scanning and the GW4 consortium.
He outlines PET scanning and some of the advantages it has over CT and MRI scanning.
However, it historically has had logistical challenges including the production of certain probes.
Prof Marshall's centre in Cardiff has managed to improve this process tenfold with one particular agent, and this allows many centres around the UK to use their PET scanning facilities more regularly.
Customised colorectal cancer early diagnosis programme can identify advanced adenomas and early-stage cancer
Tele-mentoring: Impact of project ECHO
Best practice in HRRm testing in patients with metastatic prostate cancer
SABCS 2023: Latest breast cancer diagnostics guidelines
Genomic testing: Awareness and effective communication between healthcare professionals and patients
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
Choosing Wisely in radiology Tanzania
Why tumour markers are not recommended as screening tests
Choosing Wisely to mitigate financial toxicity in cancer care in Africa
